- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.89 Å
- Oligo State
- homo-hexamer
- Ligands
- 18 x MG: MAGNESIUM ION(Non-covalent)
- 42 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.4: 5 residues within 4Å:- Chain A: S.431, L.432, L.434
- Chain E: V.357, S.358
Ligand excluded by PLIPEDO.6: 6 residues within 4Å:- Chain A: G.77, K.83, D.299, E.300, T.328, N.329
Ligand excluded by PLIPEDO.7: 6 residues within 4Å:- Chain A: T.440, Q.441, Y.442, M.443, K.444
- Chain E: G.331
Ligand excluded by PLIPEDO.8: 3 residues within 4Å:- Chain A: G.89, Q.92
- Ligands: EDO.9
Ligand excluded by PLIPEDO.9: 3 residues within 4Å:- Chain A: Q.44, R.53
- Ligands: EDO.8
Ligand excluded by PLIPEDO.10: 6 residues within 4Å:- Chain A: P.79, G.80, T.81, G.82, K.83, T.84
Ligand excluded by PLIPEDO.11: 6 residues within 4Å:- Chain A: V.380, E.381, S.410, C.413, R.414, T.419
Ligand excluded by PLIPEDO.15: 5 residues within 4Å:- Chain B: S.431, L.432, L.434
- Chain F: V.357, S.358
Ligand excluded by PLIPEDO.17: 6 residues within 4Å:- Chain B: G.77, K.83, D.299, E.300, T.328, N.329
Ligand excluded by PLIPEDO.18: 6 residues within 4Å:- Chain B: T.440, Q.441, Y.442, M.443, K.444
- Chain F: G.331
Ligand excluded by PLIPEDO.19: 3 residues within 4Å:- Chain B: G.89, Q.92
- Ligands: EDO.20
Ligand excluded by PLIPEDO.20: 3 residues within 4Å:- Chain B: Q.44, R.53
- Ligands: EDO.19
Ligand excluded by PLIPEDO.21: 6 residues within 4Å:- Chain B: P.79, G.80, T.81, G.82, K.83, T.84
Ligand excluded by PLIPEDO.22: 6 residues within 4Å:- Chain B: V.380, E.381, S.410, C.413, R.414, T.419
Ligand excluded by PLIPEDO.26: 5 residues within 4Å:- Chain C: S.431, L.432, L.434
- Chain D: V.357, S.358
Ligand excluded by PLIPEDO.28: 6 residues within 4Å:- Chain C: G.77, K.83, D.299, E.300, T.328, N.329
Ligand excluded by PLIPEDO.29: 6 residues within 4Å:- Chain C: T.440, Q.441, Y.442, M.443, K.444
- Chain D: G.331
Ligand excluded by PLIPEDO.30: 3 residues within 4Å:- Chain C: G.89, Q.92
- Ligands: EDO.31
Ligand excluded by PLIPEDO.31: 3 residues within 4Å:- Chain C: Q.44, R.53
- Ligands: EDO.30
Ligand excluded by PLIPEDO.32: 6 residues within 4Å:- Chain C: P.79, G.80, T.81, G.82, K.83, T.84
Ligand excluded by PLIPEDO.33: 6 residues within 4Å:- Chain C: V.380, E.381, S.410, C.413, R.414, T.419
Ligand excluded by PLIPEDO.37: 5 residues within 4Å:- Chain B: V.357, S.358
- Chain D: S.431, L.432, L.434
Ligand excluded by PLIPEDO.39: 6 residues within 4Å:- Chain D: G.77, K.83, D.299, E.300, T.328, N.329
Ligand excluded by PLIPEDO.40: 6 residues within 4Å:- Chain B: G.331
- Chain D: T.440, Q.441, Y.442, M.443, K.444
Ligand excluded by PLIPEDO.41: 3 residues within 4Å:- Chain D: G.89, Q.92
- Ligands: EDO.42
Ligand excluded by PLIPEDO.42: 3 residues within 4Å:- Chain D: Q.44, R.53
- Ligands: EDO.41
Ligand excluded by PLIPEDO.43: 6 residues within 4Å:- Chain D: P.79, G.80, T.81, G.82, K.83, T.84
Ligand excluded by PLIPEDO.44: 6 residues within 4Å:- Chain D: V.380, E.381, S.410, C.413, R.414, T.419
Ligand excluded by PLIPEDO.48: 5 residues within 4Å:- Chain C: V.357, S.358
- Chain E: S.431, L.432, L.434
Ligand excluded by PLIPEDO.50: 6 residues within 4Å:- Chain E: G.77, K.83, D.299, E.300, T.328, N.329
Ligand excluded by PLIPEDO.51: 6 residues within 4Å:- Chain C: G.331
- Chain E: T.440, Q.441, Y.442, M.443, K.444
Ligand excluded by PLIPEDO.52: 3 residues within 4Å:- Chain E: G.89, Q.92
- Ligands: EDO.53
Ligand excluded by PLIPEDO.53: 3 residues within 4Å:- Chain E: Q.44, R.53
- Ligands: EDO.52
Ligand excluded by PLIPEDO.54: 6 residues within 4Å:- Chain E: P.79, G.80, T.81, G.82, K.83, T.84
Ligand excluded by PLIPEDO.55: 6 residues within 4Å:- Chain E: V.380, E.381, S.410, C.413, R.414, T.419
Ligand excluded by PLIPEDO.59: 5 residues within 4Å:- Chain A: V.357, S.358
- Chain F: S.431, L.432, L.434
Ligand excluded by PLIPEDO.61: 6 residues within 4Å:- Chain F: G.77, K.83, D.299, E.300, T.328, N.329
Ligand excluded by PLIPEDO.62: 6 residues within 4Å:- Chain A: G.331
- Chain F: T.440, Q.441, Y.442, M.443, K.444
Ligand excluded by PLIPEDO.63: 3 residues within 4Å:- Chain F: G.89, Q.92
- Ligands: EDO.64
Ligand excluded by PLIPEDO.64: 3 residues within 4Å:- Chain F: Q.44, R.53
- Ligands: EDO.63
Ligand excluded by PLIPEDO.65: 6 residues within 4Å:- Chain F: P.79, G.80, T.81, G.82, K.83, T.84
Ligand excluded by PLIPEDO.66: 6 residues within 4Å:- Chain F: V.380, E.381, S.410, C.413, R.414, T.419
Ligand excluded by PLIP- 6 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
PEG.5: 6 residues within 4Å:- Chain A: K.115, D.305, I.306, E.307, G.337
- Ligands: MG.1
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:D.305, A:E.307
PEG.16: 6 residues within 4Å:- Chain B: K.115, D.305, I.306, E.307, G.337
- Ligands: MG.12
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:D.305, B:E.307
PEG.27: 6 residues within 4Å:- Chain C: K.115, D.305, I.306, E.307, G.337
- Ligands: MG.23
2 PLIP interactions:2 interactions with chain C- Hydrogen bonds: C:D.305, C:E.307
PEG.38: 6 residues within 4Å:- Chain D: K.115, D.305, I.306, E.307, G.337
- Ligands: MG.34
2 PLIP interactions:2 interactions with chain D- Hydrogen bonds: D:D.305, D:E.307
PEG.49: 6 residues within 4Å:- Chain E: K.115, D.305, I.306, E.307, G.337
- Ligands: MG.45
2 PLIP interactions:2 interactions with chain E- Hydrogen bonds: E:D.305, E:E.307
PEG.60: 6 residues within 4Å:- Chain F: K.115, D.305, I.306, E.307, G.337
- Ligands: MG.56
2 PLIP interactions:2 interactions with chain F- Hydrogen bonds: F:D.305, F:E.307
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Silva, S.T.N. et al., X-ray structure of full-length human RuvB-Like 2 - mechanistic insights into coupling between ATP binding and mechanical action. Sci Rep (2018)
- Release Date
- 2018-08-08
- Peptides
- RuvB-like 2: ABCDEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
AE
AF
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.89 Å
- Oligo State
- homo-hexamer
- Ligands
- 18 x MG: MAGNESIUM ION(Non-covalent)
- 42 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 6 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Silva, S.T.N. et al., X-ray structure of full-length human RuvB-Like 2 - mechanistic insights into coupling between ATP binding and mechanical action. Sci Rep (2018)
- Release Date
- 2018-08-08
- Peptides
- RuvB-like 2: ABCDEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
AE
AF
A